Today: 9 April 2026
Subscribe
Browse Category

BSE:532822 2 December 2025 - 23 December 2025

Vodafone Idea Ltd Stock on 23 December 2025: Vi Share Price Near 52-Week High as ₹3,300 Crore NCD Boost Meets AGR Relief Hopes — Analyst Targets, Triggers, and Key Risks

Vodafone Idea Ltd Stock on 23 December 2025: Vi Share Price Near 52-Week High as ₹3,300 Crore NCD Boost Meets AGR Relief Hopes — Analyst Targets, Triggers, and Key Risks

Vodafone Idea shares traded near ₹12 on December 23, 2025, close to their 52-week high after its subsidiary completed a ₹3,300 crore fundraise via secured NCDs. The stock’s rally follows fresh funding and policy news, with proceeds aimed at meeting network investment obligations. The company remains under pressure from large statutory dues and refinancing risks.
23 December 2025
··
Vodafone Idea (IDEA) Stock on Dec 22, 2025: ₹3,300-Crore Bond Deal Draws Big NBFC Money as AGR Relief Hopes Build

Vodafone Idea (IDEA) Stock on Dec 22, 2025: ₹3,300-Crore Bond Deal Draws Big NBFC Money as AGR Relief Hopes Build

Vodafone Idea raised ₹3,300 crore through debentures, with Tata Capital investing about ₹500 crore, as banks remain cautious. The funds will support capex and repay obligations tied to fibre asset transfers. Investors are watching for possible government relief on the company’s AGR dues, which remain its biggest financial risk.
22 December 2025
··
Vodafone Idea Share Price in Focus on Dec 21, 2025: AGR Relief Buzz, ₹3,300 Crore Fundraise, and What Analysts Forecast for Vi Stock

Vodafone Idea Share Price in Focus on Dec 21, 2025: AGR Relief Buzz, ₹3,300 Crore Fundraise, and What Analysts Forecast for Vi Stock

Vodafone Idea shares closed at ₹11.96 on Dec 19, up sharply and nearly 49% higher year-to-date. On Dec 18, its infrastructure arm raised ₹3,300 crore via secured NCDs, with strong investor demand. The stock has swung from a 52-week low of ₹6.12 in August to a high of ₹12.03 in December. Markets remain focused on funding developments and possible government relief on AGR dues.
21 December 2025
··
Vodafone Idea Share Price Today (Dec 20, 2025): Vi Stock Jumps on ₹3,300 Crore NCD Fundraise as AGR Relief Talk Builds

Vodafone Idea Share Price Today (Dec 20, 2025): Vi Stock Jumps on ₹3,300 Crore NCD Fundraise as AGR Relief Talk Builds

Vodafone Idea shares closed at ₹11.96 on Dec 19, up 5.84%, after confirming a ₹3,300 crore fundraise through secured NCDs. Trading volume hit 1.24 billion shares. The rally follows renewed speculation of government relief on AGR dues, including a possible moratorium and waivers. Investors are watching for further tariff hikes and legal developments.
20 December 2025
··
Vodafone Idea Share Price Weekly Outlook: Vi Stock Near 52-Week High on AGR Relief Hopes, Fresh Funding Moves (Updated 14 Dec 2025)

Vodafone Idea Share Price Weekly Outlook: Vi Stock Near 52-Week High on AGR Relief Hopes, Fresh Funding Moves (Updated 14 Dec 2025)

Vodafone Idea shares closed Friday at ₹11.64, near a 52-week high after a late-week rally and heavy trading volumes. The surge followed board approval for a ₹3,300 crore debt issue at its subsidiary, backed by a corporate guarantee and share pledge. Investors focused on renewed hopes for government relief on AGR dues and signs of progress in the company’s funding plans.
14 December 2025
··
Vodafone Idea share price today: Vi stock hits fresh 52-week high; AGR relief hopes, funding moves and analyst targets (Dec 13, 2025)

Vodafone Idea share price today: Vi stock hits fresh 52-week high; AGR relief hopes, funding moves and analyst targets (Dec 13, 2025)

Vodafone Idea shares hit a 52-week high at ₹11.70 on December 12, closing up 3.47% amid heavy trading volumes. The surge follows renewed hopes for government relief on adjusted gross revenue dues and ongoing funding efforts. The Supreme Court has allowed the government to reconsider AGR demands. The government now holds a 48.99% stake in the company.
13 December 2025
··
Vodafone Idea Share Price Near 52-Week High: AGR Relief Hopes, Fundraising and Tariff Buzz Fuel Rally

Vodafone Idea Share Price Near 52-Week High: AGR Relief Hopes, Fundraising and Tariff Buzz Fuel Rally

Vodafone Idea shares traded near a 52-week high on December 10, hitting ₹11.07 before settling around ₹10.8–10.9, after heavy volumes of 22.5 crore shares and turnover of ₹245 crore. The stock has surged 55% in six months and rebounded over 80% from its August low, fueled by improving results and hopes for regulatory relief on AGR dues. Brokerages raised target prices but see limited further upside.
10 December 2025
··
Vodafone Idea Share Price Today: AGR Relief Hopes, Debt Overhang and 5G Rollout Shape the Next Move

Vodafone Idea Share Price Today: AGR Relief Hopes, Debt Overhang and 5G Rollout Shape the Next Move

Vodafone Idea traded around ₹10.5 per share on 5 December 2025, near its 52-week high after a sharp rally fueled by hopes of government relief on AGR dues. Volumes reached 240–280 million shares, keeping it among the most active mid-caps. The stock remains heavily leveraged and dependent on policy decisions, with analysts citing negative net worth and funding needs.
5 December 2025
···
Vodafone Idea Share Price Today, December 2, 2025: AGR Relief Hopes Ignite Rally as Tariff Hikes and 5G Push Shape the Next Move

Vodafone Idea Share Price Today, December 2, 2025: AGR Relief Hopes Ignite Rally as Tariff Hikes and 5G Push Shape the Next Move

Vodafone Idea shares rose 2–3% to trade between ₹10.11 and ₹10.32 on December 2, with over 23 crore shares changing hands—triple the 30-day average volume. The rally followed government comments on possible AGR dues relief, though the BSE has asked the company for clarification. Derivatives trading showed mixed sentiment. Analyst targets remain below current prices, with most ratings at “Hold” or “Sell.”
2 December 2025
···

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:15 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop